MedTrace Logo

A Clinical Study to Evaluate the Efficacy and Safety of Monopolar Radiofrequency Combined With SkinCeuticals A.G.E and Skinceuticals CE FERULIC for Improving Facial Skin Elasticity, Tightening and Fading Fine Lines

NCT06228833 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-01-29

No results posted yet for this study

Summary

A Prospective, Single-center, Single-blind, Randomized split-face, controlled trial will be conducted. The goal of this clinical trial is to evaluate the efficacy and safety of monopolar radiofrequency combined with SkinCeuticals A.G.E and Skinceuticals CE FERULIC for improving facial skin elasticity, tightening and fading fine lines

Conditions

  • Skin Aging

Interventions

DEVICE

monopolar radiofrequency

Each subject underwent monopolar radiofrequency treatment (Thermage FLX ™ ) on both sides of the face

OTHER

SkinCeuticals A.G.E and Skinceuticals CE FERULIC

Test Side receives SkinCeuticals A.G.E and Skinceuticals CE FERULIC

OTHER

Standard Cream

Control Side applies Standard Cream

Sponsors & Collaborators

  • Yes Skin Medical Group

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-30
Primary Completion
2024-03-30
Completion
2024-10-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06228833 on ClinicalTrials.gov